Patrick F. Kelly is SVP, Chief Medical Officer of Forma Therapeutics Holdings, Inc.. Currently has a direct ownership of 104,884 shares of FMTX, which is worth approximately $0. The most recent transaction as insider was on Apr 08, 2022, when has been sold 15,000 shares (Common Stock) at a price of $5.05 per share, resulting in proceeds of $75,750. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 105K
0% 3M change
0% 12M change
Total Value Held $0

Patrick F. Kelly Transaction History

Date Transaction Value Shares Traded Shares Held Form
Apr 08 2022
BUY
Exercise of conversion of derivative security
$75,750 $5.05 p/Share
15,000 Added 12.51%
104,884 Common Stock
Feb 28 2022
BUY
Grant, award, or other acquisition
-
25,000 Added 21.76%
89,884 Common Stock
Feb 23 2022
SELL
Open market or private sale
$51,296 $9.78 p/Share
5,245 Reduced 7.48%
64,884 Common Stock
Feb 26 2021
BUY
Grant, award, or other acquisition
-
27,170 Added 50.0%
27,170 Common Stock
PFK

Patrick F. Kelly

SVP, Chief Medical Officer
Watertown, MA

Track Institutional and Insider Activities on FMTX

Follow Forma Therapeutics Holdings, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells FMTX shares.

Notify only if

Insider Trading

Get notified when an Forma Therapeutics Holdings, Inc. insider buys or sells FMTX shares.

Notify only if

News

Receive news related to Forma Therapeutics Holdings, Inc.

Track Activities on FMTX